← Back to Search

Treatment for Shoulder Arthroscopy

Phase 4
Waitlist Available
Led By James M Gregory, MD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Undergo arthroscopic shoulder surgery in the seated upright (beach-chair) position requiring visualization within the subacromial space
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up end of surgery(about 30-120 minutes from start of surgery)
Awards & highlights

Study Summary

The purpose of this study is to evaluate surgeon-rated visual clarity and the need for increased irrigation pump pressure during arthroscopic shoulder surgery and to evaluate mean arterial pressure, operative time, and any adverse events that occur during arthroscopic shoulder surgery.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~end of surgery(about 30-120 minutes from start of surgery)
This trial's timeline: 3 weeks for screening, Varies for treatment, and end of surgery(about 30-120 minutes from start of surgery) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of Participants for Whom Intra-operative Arthroscopic Pump Pressure Was Increased to 45mmHg or Higher During the Surgical Procedure
Surgeon-rated Visual Clarity as Assessed by the Visual Analog Scale
Secondary outcome measures
Intraoperative Mean Arterial Pressure
Number of Subjects Who Experience Intraoperative Adverse Events
Number of Subjects Who Experience Post Operative Adverse Events
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: TreatmentExperimental Treatment1 Intervention
Group II: Control GroupActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Bupivacaine with Epinephrine
2013
Completed Phase 4
~90

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center, HoustonLead Sponsor
903 Previous Clinical Trials
320,917 Total Patients Enrolled
James M Gregory, MDPrincipal InvestigatorThe University of Texas Health Science Center, Houston
2 Previous Clinical Trials
70 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Subacromial Injection of Epinephrine Improves Visualization in Shoulder Arthroscopy
James M. Gregory 2022. "Subacromial Injection of Epinephrine Improves Visualization in Shoulder Arthroscopy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05244525.
~19 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top